{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:01:25Z","timestamp":1787788885584,"version":"build-2784847793"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03302-0","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T09:31:55Z","timestamp":1784971915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Baseline, repeated-measure burden, and two-time-point patterns of the triglyceride-glucose index-visceral lipid ratio (TyG-VLR) and incident cardiovascular disease in cardiovascular-kidney-metabolic (CKM) syndrome stages 0\u20133: a longitudinal China Health and Retirement Longitudinal Study (CHARLS) analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Ao-Men","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Jie","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang-Ke","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"3302_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982\u20133021. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.010.","journal-title":"J Am Coll Cardiol"},{"key":"3302_CR2","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1016\/S2468-2667(21)00228-0","volume":"6","author":"Q Ma","year":"2021","unstructured":"Ma Q, Li R, Wang L, Yin P, Wang Y, Yan C, et al. Temporal trend and attributable risk factors of stroke burden in China, 1990\u20132019: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2021;6:e897-906. https:\/\/doi.org\/10.1016\/S2468-2667(21)00228-0.","journal-title":"Lancet Public Health"},{"key":"3302_CR3","doi-asserted-by":"publisher","unstructured":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: A systematic analysis for the global burden of disease study 2019. Lancet Neurol. 20:795\u2013820. (2021) https:\/\/doi.org\/10.1016\/S1474-4422(21)00252-0","DOI":"10.1016\/S1474-4422(21)00252-0"},{"key":"3302_CR4","doi-asserted-by":"publisher","unstructured":"Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 23:973\u20131003. (2024) https:\/\/doi.org\/10.1016\/S1474-4422(24)00369-7","DOI":"10.1016\/S1474-4422(24)00369-7"},{"key":"3302_CR5","doi-asserted-by":"publisher","unstructured":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Lond Engl. 403: 2133\u201361. (2024) https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8","DOI":"10.1016\/S0140-6736(24)00757-8"},{"key":"3302_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43:61\u20138. https:\/\/doi.org\/10.1093\/ije\/dys203.","journal-title":"Int J Epidemiol"},{"key":"3302_CR7","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association. Circulation. 2023;148:1606\u201335. https:\/\/doi.org\/10.1161\/CIR.0000000000001184.","journal-title":"Circulation"},{"key":"3302_CR8","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011\u20132020. JAMA. 2024;331:1858\u201360. https:\/\/doi.org\/10.1001\/jama.2024.6892.","journal-title":"JAMA"},{"key":"3302_CR9","doi-asserted-by":"publisher","first-page":"e2445309","DOI":"10.1001\/jamanetworkopen.2024.45309","volume":"7","author":"R Zhu","year":"2024","unstructured":"Zhu R, Wang R, He J, Wang L, Chen H, Niu X, et al. Prevalence of cardiovascular-kidney-metabolic syndrome stages by social determinants of health. JAMA Netw Open. 2024;7:e2445309. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.45309.","journal-title":"JAMA Netw Open."},{"key":"3302_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03266-1","author":"Y Huang","year":"2026","unstructured":"Huang Y, Qu X, Xu S, Zhen P, Yao M, Luo J, et al. Optimizing early triage for subclinical cardiovascular-kidney-metabolic syndrome: longitudinal associations, incremental value, and clinical utility of nine insulin resistance surrogates. Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03266-1.","journal-title":"Cardiovasc Diabetol"},{"key":"3302_CR11","doi-asserted-by":"publisher","first-page":"38214","DOI":"10.1038\/srep38214","volume":"6","author":"M-F Xia","year":"2016","unstructured":"Xia M-F, Chen Y, Lin H-D, Ma H, Li X-M, Aleteng Q, et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci Rep. 2016;6:38214. https:\/\/doi.org\/10.1038\/srep38214.","journal-title":"Sci Rep"},{"key":"3302_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12933-021-01268-9","volume":"20","author":"X Ding","year":"2021","unstructured":"Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20:76. https:\/\/doi.org\/10.1186\/s12933-021-01268-9.","journal-title":"Cardiovasc Diabetol."},{"key":"3302_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12933-023-02114-w","volume":"23","author":"F Li","year":"2024","unstructured":"Li F, Wang Y, Shi B, Sun S, Wang S, Pang S, et al. Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China. Cardiovasc Diabetol. 2024;23:16. https:\/\/doi.org\/10.1186\/s12933-023-02114-w.","journal-title":"Cardiovasc Diabetol."},{"key":"3302_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12933-024-02518-2","volume":"23","author":"Y Yang","year":"2024","unstructured":"Yang Y, Li S, Ren Q, Qiu Y, Pan M, Liu G, et al. The interaction between triglyceride-glucose index and visceral adiposity in cardiovascular disease risk: findings from a nationwide Chinese cohort. Cardiovasc Diabetol. 2024;23:427. https:\/\/doi.org\/10.1186\/s12933-024-02518-2.","journal-title":"Cardiovasc Diabetol."},{"key":"3302_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12933-025-03063-2","volume":"25","author":"W Zheng","year":"2026","unstructured":"Zheng W, Man Z, Li Y, Zhu X. Association between the triglyceride glucose index: Chinese visceral adiposity index (TyG-CVAI) and new-onset cardiovascular disease in middle-aged and older adults-insights from the China health and retirement longitudinal study (CHARLS). Cardiovasc Diabetol. 2026;25:48. https:\/\/doi.org\/10.1186\/s12933-025-03063-2.","journal-title":"Cardiovasc Diabetol."},{"key":"3302_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12933-025-02668-x","volume":"24","author":"M Wang","year":"2025","unstructured":"Wang M, Gao B, Huang F. Association between the triglyceride glucose-Chinese visceral adiposity index and new-onset stroke risk: a national cohort study. Cardiovasc Diabetol. 2025;24:119. https:\/\/doi.org\/10.1186\/s12933-025-02668-x.","journal-title":"Cardiovasc Diabetol."},{"key":"3302_CR17","doi-asserted-by":"publisher","first-page":"1284144","DOI":"10.3389\/fendo.2024.1284144","volume":"15","author":"Y Ren","year":"2024","unstructured":"Ren Y, Hu Q, Li Z, Zhang X, Yang L, Kong L. Dose-response association between Chinese visceral adiposity index and cardiovascular disease: a national prospective cohort study. Front Endocrinol. 2024;15:1284144. https:\/\/doi.org\/10.3389\/fendo.2024.1284144.","journal-title":"Front Endocrinol"},{"key":"3302_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12944-024-02105-0","volume":"23","author":"Z Lv","year":"2024","unstructured":"Lv Z, Ji Y, Xu S, Li C, Cai W. Chinese visceral adiposity index and its transition patterns: impact on cardiovascular and cerebrovascular diseases in a national cohort study. Lipids Health Dis. 2024;23:124. https:\/\/doi.org\/10.1186\/s12944-024-02105-0.","journal-title":"Lipids Health Dis"},{"key":"3302_CR19","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/s41598-025-31561-6","volume":"16","author":"L-H Huang","year":"2025","unstructured":"Huang L-H, Kang K-P. Association between changes in Chinese visceral adiposity index and cardiovascular disease among middle-aged and older Chinese adults. Sci Rep. 2025;16:1433. https:\/\/doi.org\/10.1038\/s41598-025-31561-6.","journal-title":"Sci Rep"},{"key":"3302_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","volume":"23","author":"W Li","year":"2024","unstructured":"Li W, Shen C, Kong W, Zhou X, Fan H, Zhang Y, et al. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23:292. https:\/\/doi.org\/10.1186\/s12933-024-02352-6.","journal-title":"Cardiovasc Diabetol."},{"key":"3302_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02754-0","volume":"24","author":"L Lu","year":"2025","unstructured":"Lu L, Chen Y, Liu B, Li X, Wang J, Nie Z, et al. Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24:202. https:\/\/doi.org\/10.1186\/s12933-025-02754-0.","journal-title":"Cardiovasc Diabetol"},{"key":"3302_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12933-023-02100-2","volume":"23","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen X, Shi J, Du M, Li S, Pang J, et al. Relationship between triglyceride-glucose index baselines and trajectories with incident cardiovascular diseases in the elderly population. Cardiovasc Diabetol. 2024;23:6. https:\/\/doi.org\/10.1186\/s12933-023-02100-2.","journal-title":"Cardiovasc Diabetol."},{"key":"3302_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02076-z","volume":"22","author":"H Zhou","year":"2023","unstructured":"Zhou H, Ding X, Lan Y, Chen S, Wu S, Wu D. Multi-trajectories of triglyceride-glucose index and lifestyle with cardiovascular disease: a cohort study. Cardiovasc Diabetol. 2023;22:341. https:\/\/doi.org\/10.1186\/s12933-023-02076-z.","journal-title":"Cardiovasc Diabetol"},{"key":"3302_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02880-9","volume":"24","author":"Y-C Zhao","year":"2025","unstructured":"Zhao Y-C, Wu S-Q, Li J-K, Sun Z-H, Zhang B-K, Fu R, et al. Predictive value of the combined triglyceride-glucose and frailty index for cardiovascular disease and stroke in two prospective cohorts. Cardiovasc Diabetol. 2025;24:318. https:\/\/doi.org\/10.1186\/s12933-025-02880-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3302_CR25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"key":"3302_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02616-9","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wu J, Li T, Qu Y, Wang Y. Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes. Cardiovasc Diabetol. 2025;24:52. https:\/\/doi.org\/10.1186\/s12933-025-02616-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3302_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02724-6","volume":"24","author":"B Wang","year":"2025","unstructured":"Wang B, Li L, Tang Y, Ran X. Joint association of triglyceride glucose index (TyG) and body roundness index (BRI) with stroke incidence: a national cohort study. Cardiovasc Diabetol. 2025;24:164. https:\/\/doi.org\/10.1186\/s12933-025-02724-6.","journal-title":"Cardiovasc Diabetol"},{"key":"3302_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02569-5","volume":"24","author":"R Zhang","year":"2025","unstructured":"Zhang R, Hong J, Wu Y, Lin L, Chen S, Xiao Y. Joint association of triglyceride glucose index (TyG) and a body shape index (ABSI) with stroke incidence: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24:7.","journal-title":"Cardiovasc Diabetol"},{"key":"3302_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03195-z","author":"X Shao","year":"2026","unstructured":"Shao X, Yu T, Luo L, Zheng H, Yang F, Dong J. LDL-C combined with Chinese visceral adiposity index as a risk stratification tool for cardiometabolic multimorbidity in middle-aged and older Chinese adults: a national prospective cohort study. Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03195-z.","journal-title":"Cardiovasc Diabetol."},{"key":"3302_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12933-025-02589-9","volume":"24","author":"G Zheng","year":"2025","unstructured":"Zheng G, Jin J, Wang F, Zheng Q, Shao J, Yao J, et al. Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24:22. https:\/\/doi.org\/10.1186\/s12933-025-02589-9.","journal-title":"Cardiovasc Diabetol."},{"key":"3302_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12933-024-02256-5","volume":"23","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Zhao L, Lu Y, Xiao Y, Zhou X. Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study. Cardiovasc Diabetol. 2024;23:194. https:\/\/doi.org\/10.1186\/s12933-024-02256-5.","journal-title":"Cardiovasc Diabetol."},{"key":"3302_CR32","doi-asserted-by":"publisher","first-page":"e1916591","DOI":"10.1001\/jamanetworkopen.2019.16591","volume":"2","author":"H Li","year":"2019","unstructured":"Li H, Zheng D, Li Z, Wu Z, Feng W, Cao X, et al. Association of depressive symptoms with incident cardiovascular diseases in middle-aged and older Chinese adults. JAMA Netw Open. 2019;2:e1916591. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.16591.","journal-title":"JAMA Netw Open"},{"key":"3302_CR33","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"key":"3302_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01870-z","volume":"22","author":"Y Wu","year":"2023","unstructured":"Wu Y, Yang Y, Zhang J, Liu S, Zhuang W. The change of triglyceride-glucose index may predict incidence of stroke in the general population over 45 years old. Cardiovasc Diabetol. 2023;22:132. https:\/\/doi.org\/10.1186\/s12933-023-01870-z.","journal-title":"Cardiovasc Diabetol"},{"key":"3302_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02281-4","volume":"23","author":"X Zhu","year":"2024","unstructured":"Zhu X, Xu W, Song T, Wang X, Wang Q, Li J, et al. Changes in the combination of the triglyceride-glucose index and obesity indicators estimate the risk of cardiovascular disease. Cardiovasc Diabetol. 2024;23:192. https:\/\/doi.org\/10.1186\/s12933-024-02281-4.","journal-title":"Cardiovasc Diabetol"},{"key":"3302_CR36","doi-asserted-by":"publisher","first-page":"154766","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766. https:\/\/doi.org\/10.1016\/j.metabol.2021.154766.","journal-title":"Metabolism"},{"key":"3302_CR37","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459\u201372. https:\/\/doi.org\/10.1093\/eurheartj\/ehx144.","journal-title":"Eur Heart J."},{"key":"3302_CR38","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland IJ, Ross R, Despr\u00e9s J-P, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: A position statement. Lancet Diabetes Endocrinol England. 2019;7:715\u201325. https:\/\/doi.org\/10.1016\/S2213-8587(19)30084-1.","journal-title":"Lancet Diabetes Endocrinol England"},{"key":"3302_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-117","volume":"11","author":"J Frosteg\u00e5rd","year":"2013","unstructured":"Frosteg\u00e5rd J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013;11:117. https:\/\/doi.org\/10.1186\/1741-7015-11-117.","journal-title":"BMC Med"},{"key":"3302_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07166-8","volume":"15","author":"A Ajoolabady","year":"2024","unstructured":"Ajoolabady A, Pratico D, Lin L, Mantzoros CS, Bahijri S, Tuomilehto J, et al. Inflammation in atherosclerosis: pathophysiology and mechanisms. Cell Death Dis. 2024;15:817. https:\/\/doi.org\/10.1038\/s41419-024-07166-8.","journal-title":"Cell Death Dis"},{"key":"3302_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12933-024-02122-4","volume":"23","author":"R-R Huo","year":"2024","unstructured":"Huo R-R, Liao Q, Zhai L, You X-M, Zuo Y-L. Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on stroke risk and the mediating role of TyG in middle-aged and older Chinese adults: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23:30. https:\/\/doi.org\/10.1186\/s12933-024-02122-4.","journal-title":"Cardiovasc Diabetol."},{"key":"3302_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-026-02221-0","author":"AM Lu","year":"2026","unstructured":"Lu AM, Xu Q, Wu YT. Trajectories, cumulative burden of the dynamic triglyceride glucose-Chinese visceral adiposity index, and risk of incident cardiovascular diseases: a large prospective cohort study. Diabetol Metab Syndr. 2026. https:\/\/doi.org\/10.1186\/s13098-026-02221-0.","journal-title":"Diabetol Metab Syndr"},{"key":"3302_CR43","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s12933-025-02972-6","volume":"24","author":"C Wang","year":"2025","unstructured":"Wang C, He S, Xie G, Zhang S, Xiong Z, Lu H, et al. Associations of longitudinal trajectories of triglyceride-glucose index combined with classical and novel obesity indices and cardiovascular disease: evidence from a nationwide prospective cohort study in China. Cardiovasc Diabetol. 2025;24:431. https:\/\/doi.org\/10.1186\/s12933-025-02972-6.","journal-title":"Cardiovasc Diabetol"},{"key":"3302_CR44","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12933-024-02457-y","volume":"23","author":"J-H Lee","year":"2024","unstructured":"Lee J-H, Jeon S, Lee HS, Lee J-W. Trajectories of triglyceride-glucose index changes and their association with all-cause and cardiovascular mortality: a competing risk analysis. Cardiovasc Diabetol. 2024;23:364. https:\/\/doi.org\/10.1186\/s12933-024-02457-y.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03302-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03302-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03302-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:24:30Z","timestamp":1787747070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03302-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3302"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03302-0","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"30 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Biomedical Ethics Review Board of Peking University (approval numbers IRB00001052-11015 and IRB00001052-11014). The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. All participants were informed about the purpose of the study, assured of confidentiality, and provided written consent prior to participation.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"221"}}